A Greater Cincinnati public company in the midst of a merger with a California-based competitor is selling some of its top intellectual property to the tune of nearly $500,000.
Aerpio Pharmaceuticals (Nasdaq: ARPO), a Blue Ash-based biopharma company, entered into an asset purchase agreement earlier this month with EyePoint Pharmaceuticals, headquartered in Watertown, Mass., per a Securities and Exchange Commission filing.
Click here to read the complete story.
Story excerpt provided by Cincinnati Business Courier.
Written by Liz Engel.
Originally published August 25, 2021.